EP2985039
Staðbundin notkun bótúlín-eiturefna og lyfjagjöf þeirra gegnum húð
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
3.3.2005EP published:
1.8.2018EP application number:
15185714.1
EP translation filed:
29.10.2018Grant published:
15.12.2018EPO information:
European Patent Register
Max expiry date:
2.3.2025Expiry date:
2.3.2025
Title:
TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS
Timeline
Today
3.3.2005EP application
1.8.2018EP Publication
29.10.2018Translation submitted
15.12.2018Registration published
2.3.2025Expires
Owner
Name:
ReVance Therapeutics, Inc.Address:
7555 Gateway Blvd., 94560, Newark, CA, US
Inventor
Name:
Dake, Michael D.Address:
Stanford, CA, US
Name:
Waugh, Jacob M.Address:
Palo Alto, CA, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
550015 PDate:
3.3.2004Country:
US
Classification
Categories:
A61K 51/00, A61K 39/42, A61K 39/40, A61K 47/18, A61K 47/42
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 8.3.2019
Expires: 2.3.2020
Payer: Árnason Faktor
Number: 16
Paid: 13.3.2020
Expires: 2.3.2021
Payer: Örn Þór slf.
Number: 17
Paid: 10.2.2021
Expires: 2.3.2022
Payer: Örn Þór slf.
Number: 18
Paid: 22.4.2022
Expires: 2.3.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 12.2.2023
Expires: 2.3.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 26.3.2024
Expires: 2.3.2025
Payer: Árnason Faktor ehf.